A brave new world of prenatal DNA sequencing

| | January 30, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an excerpt.

Conventional methods for checking a baby’s genome for abnormalities require invasive procedures, such as using a needle to withdraw some amniotic fluid surrounding the fetus or some cells from the placenta, methods that can sometimes cause a miscarriage.

These tests mainly focus on abnormal numbers of certain chromosomes (such as the condition that causes Down syndrome) and are offered only to women with high-risk pregnancies. But much more could be gleaned from the fetal DNA floating in mom’s blood, and some believe that such tests will soon be available to many women.

Read the full article here: A Brave New World of Prenatal DNA Sequencing

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend